Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01942876 · ClinicalTrials.gov registry record · Phase 2
Preventing Drug Use in Low Income Clinic Populations
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 411
- Enrollment target
NCT01942876 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 411 participants.
The verdict
NCT01942876, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 411 participants
- Enrollment target
Study Summary
The proposed study will address the critical need to reduce illegal drug use, in particular drug use, and the occurrence of drug-related harm in low-income racially diverse patient populations at urban primary care safety-net clinics. Since they are at risk for accelerated trajectories to drug dependence once drug use begins, low-income racially diverse populations pose particular concern for public health policy makers and drug-use prevention efforts. The study will be the first to standardize drug screening and primary-care clinician delivered brief intervention among racially diverse "at risk" drug users, that is users with casual or frequent use without the physiological or psychological manifestations of dependence, to reduce their 'at risk' use of drugs, and it may effectively interrupt their pathway to dependence.
Interventions
- BEHAVIORAL Quit Using Drugs Intervention Trial
- BEHAVIORAL Health behavior maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01942876
The ClinicalTrials.gov registry entry for NCT01942876 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quit Using Drugs Intervention Trial is the first listed.
NCT01942876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01942876 about?
NCT01942876 is a clinical study titled "Preventing Drug Use in Low Income Clinic Populations". The proposed study will address the critical need to reduce illegal drug use, in particular drug use, and the occurrence of drug-related harm in low-income racially diverse patient populations at urban primary care safety-net clinics. Since they are at risk for accelerated trajectories to drug depen...
What is the current status of trial NCT01942876?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 411 participants. The study started on 2011-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01942876?
The interventions under investigation include: Quit Using Drugs Intervention Trial (BEHAVIORAL), Health behavior maintenance (BEHAVIORAL).
Who is sponsoring clinical trial NCT01942876?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.